INS and Other metabolic disease: Thus, epigenomic mechanisms are at the interface between metabolic disorders and inflammation [4] and are implicated in inflammatory processes throughout T2DM development, which occurs when insulin secretion from pancreatic beta cells cannot sufficiently be increased to compensate for insulin resistance.